These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10378372)

  • 1. Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas.
    Peters N; Waha A; Wellenreuther R; Friedrich RE; Mautner VF; Hoffmeyer S; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Acta Neuropathol; 1999 Jun; 97(6):547-51. PubMed ID: 10378372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis.
    Johnson MR; Ferner RE; Bobrow M; Hughes RA
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):643-6. PubMed ID: 10766898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.
    Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN
    Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
    Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
    Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
    Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene.
    Viskochil D; Cawthon R; O'Connell P; Xu GF; Stevens J; Culver M; Carey J; White R
    Mol Cell Biol; 1991 Feb; 11(2):906-12. PubMed ID: 1899288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
    Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
    Serra E; Puig S; Otero D; Gaona A; Kruyer H; Ars E; Estivill X; Lázaro C
    Am J Hum Genet; 1997 Sep; 61(3):512-9. PubMed ID: 9326316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The OMgp gene, a second growth suppressor within the NF1 gene.
    Habib AA; Gulcher JR; Högnason T; Zheng L; Stefánsson K
    Oncogene; 1998 Mar; 16(12):1525-31. PubMed ID: 9569019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning disability and oligodendrocyte myelin glycoprotein (OMGP) gene in neurofibromatosis type 1.
    Terzi YK; Oğuzkan-Balci S; Anlar B; Erdoğan-Bakar E; Ayter S
    Turk J Pediatr; 2011; 53(1):75-8. PubMed ID: 21534343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
    Kluwe L; Friedrich RE; Mautner VF
    Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
    Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
    Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
    Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
    Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in neurofibromatosis type 1.
    Arun D; Gutmann DH
    Curr Opin Neurol; 2004 Apr; 17(2):101-5. PubMed ID: 15021234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.
    Nix JS; Yuan M; Imada EL; Ames H; Marchionni L; Gutmann DH; Rodriguez FJ
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):96-107. PubMed ID: 32603552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway.
    Feldkamp MM; Angelov L; Guha A
    Surg Neurol; 1999 Feb; 51(2):211-8. PubMed ID: 10029430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1.
    Lévy P; Ripoche H; Laurendeau I; Lazar V; Ortonne N; Parfait B; Leroy K; Wechsler J; Salmon I; Wolkenstein P; Dessen P; Vidaud M; Vidaud D; Bièche I
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):398-407. PubMed ID: 17202312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.